This announcement is a separate document:
上海市锦天城律师事务所关于安图生物2023年度差异化分红事项的法律意见书
Legal Opinion of Shanghai AllBright Law Firm on Antu Biotech's 2023 Differential Dividend
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.